Biology of Blood and Marrow Transplantation
Volume 11, Issue 12 , Pages 957-971 , December 2005

Cytolytic Pathways Used by Effector Cells Derived from Recipient Naive and Memory T Cells and Natural Killer Cells in Resistance to Allogeneic Hematopoietic Cell Transplantation

Received 25 April 2005 ,Accepted 11 July 2005.

References 

  1. Lowin B , Hahne M , Mattmann C , Tschopp J . Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways . Nature . 1994;370:650–652
  2. Baker MB , Podack ER , Levy RB . Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice . Biol Blood Marrow Transplant . 1995;1:69–73
  3. Shizuru JA , Jerabek L , Edwards CT , Weissman IL . Transplantation of purified hematopoietic stem cells (requirements for overcoming the barriers of allogeneic engraftment) . Biol Blood Marrow Transplant . 1996;2:3–14
  4. Graubert TA , Russell JH , Ley TJ . The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection . Blood . 1996;87:1232–1237
  5. Bennett M , Taylor PA , Austin M , et al.   Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts (influence of mouse colony environment) . Int Immunol . 1998;10:785–790
  6. Jones M , Komatsu M , Levy RB . Cytotoxically impaired transplant recipients can efficiently resist major histocompatibility complex-matched bone marrow allografts . Biol Blood Marrow Transplant . 2000;6:456–464
  7. Taylor MA , Chaudhary PM , Klem J , Kumar V , Schatzle JD , Bennett M . Inhibition of the death receptor pathway by cFLIP confers partial engraftment of MHC class I-deficient stem cells and reduces tumor clearance in perforin-deficient mice . J Immunol . 2001;167:4230–4237
  8. Taylor MA , Ward B , Schatzle JD , Bennett M . Perforin- and Fas-dependent mechanisms of natural killer cell mediated rejection of incompatible bone marrow cell grafts . Eur J Immunol . 2002;32:793–799
  9. Komatsu M , Mammolenti M , Jones M , Jurecic R , Sayers TJ , Levy RB . Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing . Blood . 2003;101:3991–3999
  10. Aguila HL , Hershberger RJ , Weissman IL . Transgenic mice carrying the diphtheria toxin A chain gene under the control of the granzyme A promoter (expected depletion of cytotoxic cells and unexpected depletion of CD8 T cells) . Proc Natl Acad Sci U S A . 1995;92:10192–10196
  11. Thiele DL , Lipsky PE . The immunosuppressive activity of L-leucyl-L-leucine methyl ester (selective ablation of cytotoxic lymphocytes and monocytes) . J Immunol . 1986;136:1038–1048
  12. Loughran TP , Raff RF , Graham TC , et al.   Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts . Exp Hematol . 1990;18:1126–1131
  13. Zimmerman ZF , Shatry AM , Deyev V , et al.   Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways . Biol Blood Marrow Transplant . 2005;11:576–586
  14. Storb R , Weiden PL , Graham TC , Thomas ED . Failure of engraftment and graft-versus-host disease after canine marrow transplantation. Two phenomena linked to but not exclusively determined by known antigens of the major histocompatibility complex . Transplant Proc . 1978;10:113–118
  15. Murphy WJ , Kumar V , Bennett M . Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection . J Exp Med . 1987;165:1212–1217
  16. Yankelevich B , Knobloch C , Nowicki M , Dennert G . A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts . J Immunol . 1989;142:3423–3430
  17. Raff RF , Deeg HJ , Loughran TP , et al.   Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors . Blood . 1986;68:861–868
  18. Lee LA , Sergio JJ , Sykes M . Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells . Transplantation . 1996;61:125–132
  19. Murphy WJ , Kumar V , Bennett M . Acute rejection of murine bone marrow allografts by natural killer cells and T cells (differences in kinetics and target antigens recognized) . J Exp Med . 1987;166:1499–1550
  20. Takeda K , Moore MW , Dennert G . Acute rejection of marrow grafts in mice. Dependence on and independence of functional TcR in the rejection process . J Immunol . 1994;152:4407–4416
  21. Barge AJ , Johnson G , Witherspoon R , Torok-Storb B . Antibody-mediated marrow failure after allogeneic bone marrow transplantation . Blood . 1989;74:1477–1480
  22. Miklos DB , Kim HT , Zorn E , et al.   Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors . Blood . 2004;103:353–359
  23. Zorn E , Miklos DB , Floyd BH , et al.   Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation . J Exp Med . 2004;199:1133–1142
  24. Grayson JM , Zajac AJ , Altman JD , Ahmed R . Cutting edge (increased expression of Bcl-2 in antigen-specific memory CD8+ T cells) . J Immunol . 2000;164:3950–3954
  25. Storb R . Critical issues in bone marrow transplantation . Transplant Proc . 1987;19:2774–2781
  26. Reisner Y , Benbassat I , Douer D , Kaploon A , Schwartz E , Ramot B . Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation . Proc Natl Acad Sci U S A . 1986;83:4012–4015
  27. Kraus AB , Shaffer J , Toh HC , et al.   Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation . Exp Hematol . 2003;31:609–621
  28. Lowry PA , Tabbara IA . Peripheral hematopoietic stem cell transplantation (current concepts) . Exp Hematol . 1992;20:937–942
  29. Jordan CT , Lemischka IR . Clonal and systemic analysis of long-term hematopoiesis in the mouse . Genes Dev . 1990;4:220–232
  30. Jones RJ , Wagner JE , Celano P , Zicha MS , Sharkis SJ . Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells . Nature . 1990;347:188–189
  31. Aguila HL , Weissman IL . Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells . Blood . 1996;87:1225–1231
  32. Koh CY , Welniak LA , Murphy WJ . Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation (effects of marrow dose) . Biol Blood Marrow Transplant . 2005;11:252–259
  33. Davenport C , Kumar V , Bennett M . Rapid rejection of H2k and H2k/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice . J Immunol . 1995;155:3742–3749
  34. Vallera DA , Taylor PA , Sprent J , Blazar BR . The role of host T-cell subsets in bone-marrow rejection directed to isolated major histocompatibility complex class-I versus class-II differences of Bm1 and Bm12 mutant mice . Transplantation . 1994;57:249–256
  35. Sprent J , Surh CD , Agus D , Hurd M , Sutton S , Heath WR . Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells . J Exp Med . 1994;180:307–317
  36. Sentman CL , Streilein R , Kumar V , et al.   Kinetics and location of bone marrow cell graft rejection by irradiated mice . Nat Immun Cell Growth Regul . 1988;7:95–105
  37. Shatry AM , Jones M , Levy RB . The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants . Stem Cells Dev . 2004;13:51–62
  38. Dennert G , Anderson CG , Warner J . T-killer cells play a role in allogeneic bone-marrow graft-rejection but not in hybrid resistance . J Immunol . 1985;135:3729–3734
  39. Scheffold C , Scheffold YC , Cao TM , Gworek J , Shizuru JA . Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells . Biol Blood Marrow Transplant . 2005;11:1–12
  40. Cudkowicz G , Bennett M . Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice . J Exp Med . 1971;134:83–102
  41. Kiessling R , Hochman PS , Haller O , Shearer GM , Wigzell H , Cudkowicz G . Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts . Eur J Immunol . 1977;7:655–663
  42. Barao I , Murphy WJ . The immunobiology of natural killer cells and bone marrow allograft rejection . Biol Blood Marrow Transplant . 2003;9:727–741
  43. Liao NS , Bix M , Zijlstra M , Jaenisch R , Raulet D . MHC class I deficiency (susceptibility to natural killer (NK) cells and impaired NK activity) . Science . 1991;253:199–202
  44. Ljunggren HG , Karre K . In search of the ‘missing self’ (MHC molecules and NK cell recognition) . Immunol Today . 1990;11:237–244
  45. Anderson SK , Ortaldo JR , McVicar DW . The ever-expanding Ly49 gene family (repertoire and signaling) . Immunol Rev . 2001;181:79–89
  46. McLaren FH , Svendsen CN , Van der Meide P , Joly E . Analysis of neural stem cells by flow cytometry (cellular differentiation modifies patterns of MHC expression) . J Neuroimmunol . 2001;112:35–46
  47. Modo M , Mellodew K , Rezaie P . In vitro expression of major histocompatibility class I and class II antigens by conditionally immortalized murine neural stem cells . Neurosci Lett . 2003;337:85–88
  48. Mammolenti M , Gajavelli S , Tsoulfas P , Levy R . Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro . Stem Cells . 2004;22:1101–1110
  49. Drukker M , Katz G , Urbach A , et al.   Characterization of the expression of MHC proteins in human embryonic stem cells . Proc Natl Acad Sci U S A . 2002;99:9864–9869
  50. Bartholomew A , Sturgeon C , Siatskas M , et al.   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo . Exp Hematol . 2002;30:42–48
  51. Krampera M , Glennie S , Dyson J , et al.   Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide . Blood . 2003;101:3723–3729
  52. Scott I , O’Shea J , Bunce M , et al.   Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs (implications for unrelated bone marrow donor selection) . Blood . 1998;92:4864–4871
  53. Ruggeri L , Capanni M , Urbani E , et al.   Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants . Science . 2002;295:2097–2100
  54. Koenecke C , Shaffer J , Alexander SI , et al.   NK cell recovery, chimerism, function and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507 . Exp Hematol . 2003;31:911–923
  55. Young JD , Hengartner H , Podack ER , Cohn ZA . Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity . Cell . 1986;44:849–859
  56. Arase H , Arase N , Saito T . Fas-mediated cytotoxicity by freshly isolated natural-killer-cells . J Exp Med . 1995;181:1235–1238
  57. Kagi D , Ledermann B , Burki K , et al.   Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice . Nature . 1994;369:31–37
  58. Oshimi Y , Oda S , Honda Y , Nagata S , Miyazaki S . Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells . J Immunol . 1996;157:2909–2915
  59. Kayagaki N , Yamaguchi N , Nakayama M , et al.   Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells . J Immunol . 1999;163:1906–1913
  60. Degliantoni G , Murphy M , Kobayashi M , Francis MK , Perussia B , Trinchieri G . Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon . J Exp Med . 1985;162:1512–1530
  61. Thorburn A . Death receptor-induced cell killing . Cell Signal . 2004;16:139–144
  62. Maciejewski J , Selleri C , Anderson S , Young NS . Fas Antigen expression on CD34(+) human marrow-cells is induced by interferon-gamma and tumor-necrosis-factor-alpha and potentiates cytokine-mediated hematopoietic suppression in-vitro . Blood . 1995;85:3183–3190
  63. Sato T , Selleri C , Young NS , Maciejewski JP . Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-I . Blood . 1995;86:3373–3380
  64. Eng VM , Car BD , Schnyder B , et al.   The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon-gamma in-vivo . J Exp Med . 1995;181:1893–1898
  65. Snoeck HW , Weekx S , Moulijn A , et al.   Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma . J Exp Med . 1996;183:705–710
  66. Kawano Y , Takaue Y , Hirao A , et al.   Synergy among erythropoietin, interleukin-3, stem-cell factor (C-Kit ligand) and interferon-gamma on early human hematopoiesis . Stem Cells . 1994;12:514–520
  67. Allavena P , Scala G , Djeu JY , et al.   Production of multiple cytokines by clones of human large granular lymphocytes . Cancer Immunol Immunother . 1985;19:121–126
  68. Murphy WJ , Keller JR , Harrison CL , Young HA , Longo DL . Interleukin-2-activated natural-killer-cells can support hematopoiesis in vitro and promote marrow engraftment in vivo . Blood . 1992;80:670–677
  69. Cui H , Ju ST , Sherr DH . Functional expression of Fas (CD95) protein in autoimmune lpr mice . Cell Immunol . 1996;174:35–41
  70. Lapidot T , Faktorowich Y , Lubin I , Reisner Y . Enhancement of T-cell-depleted bone marrow allografts in the absence of graft-versus-host disease is mediated by CD8+ CD4− and not by CD8− CD4+ thymocytes . Blood . 1992;80:2406–2411
  71. Bachar-Lustig E , Rachamim N , Li HW , Lan F , Reisner Y . Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice . Nat Med . 1995;1:1268–1273
  72. Storb R , Deeg HJ , Applebaum FR , et al.   Failure of anti-Ia monoclonal antibody to abrogate transfusion-induced sensitization and prevent marrow graft rejection in DLA-identical canine littermates . Transplantation . 1988;45:505–506
  73. Storb R , Deeg HJ . Failure of allogeneic canine marrow grafts after total-body irradiation. Allogeneic “resistance” versus transfusion-induced sensitization . Transplantation . 1986;42:571–580
  74. Kernan NA , Flomenberg N , Dupont B , O’Reilly RJ . Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes . Transplantation . 1987;43:842–847
  75. Fleischhauer K , Kernan NA , O’Reilly RJ , Dupont B , Yang SY . Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44 . N Engl J Med . 1990;323:1818–1822
  76. Marijt WAF , Kernan NA , Diazbarrientos T , et al.   Multiple minor histocompatibility antigen-specific cytotoxic T-lymphocyte clones can be generated during graft-rejection after HLA-identical bone-marrow transplantation . Bone Marrow Transplant . 1995;16:125–132
  77. Fleischhauer K , Zino E , Mazzi B , et al.   Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901 . Blood . 2001;98:1122–1126
  78. Marijt WA , Veenhof WF , Goulmy E , Willemze R , van Rood JJ , Falkenburg JH . Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact . Blood . 1993;82:3778–3785
  79. Storb R , Epstein RB , Rudolph RH , Thomas ED . The effect of prior transfusion on marrow grafts between histocompatible canine siblings . J Immunol . 1970;105:627–633
  80. Storb R , Rudolph RH , Graham TC , Thomas ED . The influence of transfusions from unrelated donors upon marrow grafts between histocompatible canine siblings . J Immunol . 1971;107:409–413
  81. Storb R , Buckner CD , Fefer A , et al.   Marrow transplantation in aplastic anemia . Transplant Proc . 1974;6:355–358
  82. Deeg HJ , Shulman HM , Schmidt E , Yee GC , Thomas ED , Storb R . Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine . Transplantation . 1986;42:497–501
  83. Storb R , Prentice RL , Thomas ED . Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection . N Engl J Med . 1977;296:61–66
  84. Storb R , Thomas ED , Buckner CD , et al.   Marrow transplantation in thirty “untransfused” patients with severe aplastic anemia . Ann Intern Med . 1980;92:30–36
  85. Storb R , Prentice RL , Thomas ED , et al.   Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia . Br J Haematol . 1983;55:573–585
  86. Parkman R , Rappeport J , Camitta B , Levey RH , Nathan DG . Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients . Blood . 1978;52:1163–1169
  87. Champlin RE , Horowitz MM , van Bekkum DW , et al.   Graft failure following bone marrow transplantation for severe aplastic anemia (risk factors and treatment results) . Blood . 1989;73:606–613
  88. Loughran TP , Storb R . Treatment of aplastic anemia . Hematol Oncol Clin North Am . 1990;4:559–575
  89. Ramsay NK , Kim TH , McGlave P , et al.   Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia . Blood . 1983;62:622–626
  90. Levine P , Stetson RE . Landmark article July 8, 1939. An unusual case of intra-group agglutination. By Philip Levine and Rufus E Stetson . JAMA . 1984;251:1316–1317
  91. Van Rood JJ , Eernisse JG , Van Leeuwen A . Leucocyte antibodies in sera from pregnant women . Nature . 1958;181:1735–1736
  92. James E , Chai JG , Dewchand H , Macchiarulo E , Dazzi F , Simpson E . Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans . Blood . 2003;102:388–393
  93. Tekolf WA , Shaw S . In vitro generation of cytotoxic cells specific for human minor histocompatibility antigens by lymphocytes from a normal donor potentially primed during pregnancy . J Exp Med . 1983;157:2172–2177
  94. Singal DP , Wadia YJ , Naipaul N . In vitro cell-mediated cytotoxicity to the male specific (H-Y) antigen in man . Hum Immunol . 1981;2:45–53
  95. Mutis T , Gillespie G , Schrama E , Falkenburg JH , Moss P , Goulmy E . Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease . Nat Med . 1999;5:839–842
  96. Komlos L , Vardimon D , Notmann J , et al.   Role of children’s sex in mixed mother-child lymphocyte culture reactivity . Am J Reprod Immunol . 1990;22:4–8
  97. Verdijk RM , Kloosterman A , Pool J , et al.   Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells (implications for stem cell transplantation and immunotherapy) . Blood . 2004;103:1961–1964
  98. Gratwohl A , Baldomero H , John L , et al.   Peripheral blood pressure cells transplants across a major histocompatibility barrier in rabbits (positive effects of a higher number of precursor cells?) . Acta Haematol . 1996;95:176–180
  99. Adams AB , Williams MA , Jones TR , et al.   Heterologous immunity provides a potent barrier to transplantation tolerance . J Clin Invest . 2003;111:1887–1895
  100. Yang H , Welsh RM . Induction of allospecific and virus-specific memory cytotoxic T cells during acute arenavirus infections . Med Microbiol Immunol (Berl) . 1986;175:137–139
  101. Yang H , Welsh RM . Induction of alloreactive cytotoxic T cells by acute virus infection of mice . J Immunol . 1986;136:1186–1193
  102. Finberg R , Cantor H , Benacerraf B , Burakoff S . The origins of alloreactivity (differentiation of prekiller cells to viral infection results in alloreactive cytolytic T lymphocytes) . J Immunol . 1980;124:1858–1860
  103. London CA , Lodge MP , Abbas AK . Functional responses and costimulator dependence of memory CD4+ T cells . J Immunol . 2000;164:265–272
  104. Nakamura H , Gress RE . Graft-rejection by cytolytic T-cells—specificity of the effector mechanism in the rejection of allogeneic marrow . Transplantation . 1990;49:453–458
  105. Luznik L , Engstrom LW , Iannone R , Fuchs EJ . Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation . Biol Blood Marrow Transplant . 2002;8:131–138
  106. Baker SJ , Reddy EP . Transducers of life and death (TNF receptor superfamily and associated proteins) . Oncogene . 1996;12:1–9
  107. Chinnaiyan AM , O’Rourke K , Yu GL , et al.   Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 . Science . 1996;274:990–992
  108. Migone TS , Zhang J , Luo X , et al.   TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator . Immunity . 2002;16:479–492
  109. Kaplan MJ , Lewis EE , Shelden EA , et al.   The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells . J Immunol . 2002;169:6020–6029
  110. Nakayama M , Harada N , Okumura K , Yagita H . Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies . Biochem Biophys Res Commun . 2003;306:819–825
  111. Nakayama M , Ishidoh K , Kojima Y , et al.   Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death . J Immunol . 2003;170:341–348
  112. Kaplan MJ , Ray D , Yung RL , Richardson BC . Trail and tweak mediate antigen specific and autoreactive macrophage killing by D10 cells . [abstract] FASEB J . 2000;14:A554
  113. Madrigal JA , Scott I , Arguello R , Szydlo R , Little AM , Goldman JM . Factors influencing the outcome of bone marrow transplants using unrelated donors . Immunol Rev . 1997;157:153–166
  114. Nolte MA , Arens R , van Os R , et al.   Immune activation modulates hematopoiesis through interactions between CD27 and CD70 . Nat Immunol . 2005;6:412–418
  115. Hintzen RQ , Lens SM , Beckmann MP , Goodwin RG , Lynch D , van Lier RA . Characterization of the human CD27 ligand, a novel member of the TNF gene family . J Immunol . 1994;152:1762–1773
  116. Bourette RP , De Sepulveda P , Arnaud S , Dubreuil P , Rottapel R , Mouchiroud G . Suppressor of cytokine signaling 1 interacts with the macrophage colony-stimulating factor receptor and negatively regulates its proliferation signal . J Biol Chem . 2001;276:22133–22139
  117. Du Y , Tsai S , Keller JR , Williams SC . Identification of an interleukin-3-regulated aldoketo reductase gene in myeloid cells which may function in autocrine regulation of myelopoiesis . J Biol Chem . 2000;275:6724–6732
  118. Watanabe-Fukunaga R , Brannan CI , Copeland NG , Jenkins NA , Nagata S . Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis . Nature . 1992;356:314–317

PII: S1083-8791(05)00457-X

doi: 10.1016/j.bbmt.2005.07.006

Biology of Blood and Marrow Transplantation
Volume 11, Issue 12 , Pages 957-971 , December 2005

Article Tools

* Image Usage & Resolution